Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4 Related Diseases

NCT04539197 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT04539197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04539197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4 Related Diseases
Lead sponsor
Peking Union Medical College Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 10, 2020
Completion date
September 10, 2022
Enrollment
660 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plasmablast/plasma cells in diagnosis of igg4-rd, plasmablast/plasma cells in relapse prediction of igg4-rd